“…Based on the outcome of our editorial assessment and input received from the experts consulted in this case, the concerns noted in [ 1 ] about the scientific justification for the study, the small sample size, and support for the article’s conclusions have been dismissed. Regarding the scientific justification, a consulted expert advised that this was a pilot study to demonstrate proof-of-concept, that the study design was appropriate, and that as the 3D-printed implants were developed for use in animals an assessment of their in vivo tolerability was justified from a clinical, ethical, and regulatory perspective.…”